UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Lilly beats Pfizer in treating early breast cancer
Pfizer was the first to release a drug for the treatment of hormone recepto...
by Kim Yun-mi
|
2020-06-18 14:44
라인
‘Tecentriq, major turning point for triple-negative breast cancer treatment’
Roche Korea’s Tecentriq, the first immunotherapy to win indication for trip...
by Kim Yun-mi
|
2020-06-18 14:43
라인
IOF aims to reduce osteoporosis-related fractures by 25% by 2025
The International Osteoporosis Foundation, a non-governmental organization ...
by Kim Yun-mi
|
2020-06-17 14:28
라인
JW Pharma to recreate its anticancer therapy as Covid-19 drug
JW Pharmaceutical said Wednesday that it would reposition CWP291, its antic...
by Shim Hyun-tai
|
2020-06-17 14:26
라인
Sanofi releases hemophilia A treatment
Sanofi Aventis Korea said Tuesday that it was launching a hemophilia A trea...
by Shim Hyun-tai
|
2020-06-16 17:27
라인
Sillajen CEO steps down
Sillajen CEO Moon Eun-sang has resigned from his post.Moon’s resignation ca...
by Lee Han-soo
|
2020-06-16 16:49
라인
MSD fails to present plausible reasons, grounds for discriminating against branches
Last Thursday, MSD Korea's labor union took issue with the expanded imp...
by Lee Han-soo
|
2020-06-16 16:21
라인
Gemvax & Kael's GV1001 shows efficacy as hepatitis B treatment
Gemvax & Kael said that it has confirmed the efficacy of GV1001 in treating...
by Lee Han-soo
|
2020-06-16 16:18
라인
‘Celltrion has no reason to save Takeda Korea workers’ jobs’
Takeda Pharmaceutical’s sell-off of part of its business to Celltrion is ex...
by Kim Yun-mi
|
2020-06-16 11:44
라인
Jardiance family of diabetes drugs sells ₩10 billion in Q1
The Jardiance family of diabetes drugs, including Jardiance (empagliflozin)...
by Kim Yun-mi
|
2020-06-15 17:39
라인
Biogen’s FDA application for Alzheimer’s drug drags on
Biogen’s filing of aducanumab, an investigational Alzheimer’s drug, for U.S...
by Kim Yun-mi
|
2020-06-15 12:09
라인
Survey paints gloomy outlook for Korea’s developing Covid-19 treatment
About 60 percent of workers in the domestic pharmaceutical industry predict...
by Shim Hyun-tai
|
2020-06-12 17:56
라인
PharmAbcine inks CDMO deal with Australian firm for immunotherapy candidate
PharmAbcine, an antibody new drug developer, has signed a CDMO (contract de...
by Lee Han-soo
|
2020-06-12 17:15
라인
Regulators OKs Pharmicell’s P2 trial of erectile dysfunction treatment
Pharmicell said that the Ministry of Food and Drug Safety has approved its ...
by Lee Han-soo
|
2020-06-12 16:07
라인
Takeda’s sell-off of primary care biz to Celltrion triggers union protest
Celltrion said that it has acquired the business rights for 18 brands of Ta...
by Lee Han-soo
|
2020-06-12 15:32
라인
GC LabCell releases clinical results of NK cell therapy
GC LabCell has unveiled the study data of the combined therapy of its natur...
by Shim Hyun-tai
|
2020-06-11 17:34
라인
Genexine to start P1 trial of Covid-19 treatment in US
Genexine said NeoImmuneTech, its U.S. affiliate, has received approval from...
by Lee Han-soo
|
2020-06-11 16:26
라인
MSD Korea’s trade union refuses to use controversial monitoring program
The labor union of MSD Korea went up and arms about the company’s enhanced ...
by Kim Yun-mi
|
2020-06-11 14:31
라인
'Imfinzi changed treatment paradigm for non-resectable NSCLC'
Clinical results have shown that AstraZeneca's Imfinzi may be an effect...
by Lee Han-soo
|
2020-06-10 17:58
라인
‘Abbvie’s psoriasis drug proves long-term treatment effect’
Abbvie's Skyrizi (ingredient: risankizumab) showed the best treatment e...
by Shim Hyun-tai
|
2020-06-10 15:59
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top